Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biodelivery Sci Intl (BDSI)

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 356,646
  • Shares Outstanding, K 98,521
  • Annual Sales, $ 156,470 K
  • Annual Income, $ 25,710 K
  • 60-Month Beta 0.72
  • Price/Sales 2.30
  • Price/Cash Flow 11.11
  • Price/Book 3.42
Trade BDSI with:

Options Overview

Details
  • Implied Volatility 66.75%
  • Historical Volatility 28.19%
  • IV Percentile 31%
  • IV Rank 14.36%
  • IV High 223.27% on 09/08/20
  • IV Low 40.52% on 06/28/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 14
  • Volume Avg (30-Day) 880
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 22,287
  • Open Int (30-Day) 21,684

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.05
  • Number of Estimates 5
  • High Estimate 0.06
  • Low Estimate 0.03
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.58 +1.40%
on 07/01/21
3.93 -7.63%
on 07/07/21
-0.06 (-1.63%)
since 06/25/21
3-Month
3.06 +18.73%
on 05/11/21
3.93 -7.63%
on 07/07/21
+0.14 (+4.01%)
since 04/27/21
52-Week
3.04 +19.41%
on 10/29/20
5.45 -33.39%
on 08/14/20
-0.57 (-13.57%)
since 07/27/20

Most Recent Stories

More News
BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that...

BDSI : 3.62 (unch)
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 120.68 (+0.97%)
ACRX : 1.1800 (-2.48%)
ACOR : 3.91 (-8.86%)
AXSM : 50.53 (-2.43%)
BAYRY : 14.8100 (-2.06%)
BDRFF : 119.7000 (unch)
BDSI : 3.62 (unch)
BMY : 67.30 (-0.58%)
COLL : 24.44 (-0.69%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.03 (-0.07%)
FLXN : 5.97 (-3.86%)
GLPG : 59.44 (-1.07%)
HRTX : 12.24 (-2.47%)
KMPH : 10.47 (-2.60%)
MRK : 77.18 (-0.08%)
MESO : 6.97 (-2.65%)
NKTR : 15.86 (-2.34%)
NVS : 90.73 (-0.25%)
ORXOY : 4.4499 (-1.55%)
PFE : 41.82 (+0.02%)
REGN : 576.53 (-0.22%)
VRX.TO : 30.80 (-3.33%)
3 Biotech Stocks Wall Street Predicts Will Rally By 45% or More

The biotech industry saw solid growth last year driven by the demand for therapies to combat COVID-19. But advances in technology helped biotech companies deliver impressive drug candidates for treating...

ORGO : 14.95 (-0.07%)
BDSI : 3.62 (unch)
CSBR : 10.27 (-1.82%)
US Pain Relief Therapeutics Market Share 2021 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2027

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 120.68 (+0.97%)
ACRX : 1.1800 (-2.48%)
ACOR : 3.91 (-8.86%)
AXSM : 50.53 (-2.43%)
BAYRY : 14.8100 (-2.06%)
BDRFF : 119.7000 (unch)
BDSI : 3.62 (unch)
BMY : 67.30 (-0.58%)
COLL : 24.44 (-0.69%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.03 (-0.07%)
FLXN : 5.97 (-3.86%)
GLPG : 59.44 (-1.07%)
HRTX : 12.24 (-2.47%)
KMPH : 10.47 (-2.60%)
MRK : 77.18 (-0.08%)
MESO : 6.97 (-2.65%)
NKTR : 15.86 (-2.34%)
NVS : 90.73 (-0.25%)
ORXOY : 4.4499 (-1.55%)
PFE : 41.82 (+0.02%)
REGN : 576.53 (-0.22%)
VRX.TO : 30.80 (-3.33%)
Opioid Use Disorder Market Size 2021 | Is Projected to grow USD 4.81 billion in 2028 at a CAGR of 8.7%

Opioid Use Disorder Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional...

ALKS : 23.71 (-2.71%)
BDSI : 3.62 (unch)
HKMPF : 35.6932 (+3.49%)
ORXOY : 4.4499 (-1.55%)
PFE : 41.82 (+0.02%)
TEVA : 8.69 (-2.80%)
BioDelivery Sciences International (BDSI) Misses Q1 Earnings Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of -28.57% and 0.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

BDSI : 3.62 (unch)
BioDelivery Sciences Reports First Quarter 2021 Results

Total Company Net Revenue of $41 Million, an Increase of 7% versus Prior Year

BDSI : 3.62 (unch)
BioDelivery Sciences International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / BioDelivery Sciences International, Inc. (NASDAQ:BDSI) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6,...

BDSI : 3.62 (unch)
BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that...

BDSI : 3.62 (unch)
3 Buy-Rated Biotech Stocks Under $10

The rising prevalence of chronic disorders and the need to find cures have been driving the growth of biotech stocks. The COVID-19 pandemic has been a favorable industry backdrop over the past year, driving...

SIGA : 6.01 (-0.99%)
BDSI : 3.62 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

3rd Resistance Point 3.76
2nd Resistance Point 3.72
1st Resistance Point 3.67
Last Price 3.62
1st Support Level 3.58
2nd Support Level 3.54
3rd Support Level 3.49

See More

52-Week High 5.45
Fibonacci 61.8% 4.53
Fibonacci 50% 4.24
Fibonacci 38.2% 3.96
Last Price 3.62
52-Week Low 3.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar